Conjuvon
Brand Name: Conjuvon
Generic Name: Edaravone
Active
Registration Number
DR-XY48223
Dosage Form
Solution for IV Infusion
Issuance Date
July 26, 2022
Expiry Date
July 26, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength30mg/20mL
Packaging20 mL clear borosilicate glass ampoule (Box of 8's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Nervous System Drug
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
EdaravoneActive
Monograph: Edaravone